Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.84 – $1.02
78% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $78.7M | $124.1M | $91.4M | $88.0M | $184.2M | $135.7M | $124.5M | $140.2M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $25.7M |
| Gross profit | $78.7M | $124.1M | $91.4M | $88.0M | $184.2M | $135.7M | $124.5M | $114.5M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 81.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $70.1M | $122.3M | $89.1M | $85.0M | $182.3M | $108.5M | $122.2M | $129.8M |
| EBITDA | $74.1M | $122.3M | $89.1M | $85.0M | $182.3M | $108.5M | $122.2M | $129.9M |
| Net income | $70.1M | $122.3M | $89.1M | $85.0M | $182.3M | $108.5M | $122.2M | $129.9M |
| Net margin | 89.1% | 98.6% | 97.6% | 96.6% | 99.0% | 79.9% | 98.2% | 92.6% |
| EPS (diluted) | 0.07 | 0.09 | 0.06 | 0.06 | 0.13 | 0.08 | 0.10 | 0.11 |
Annual figures · source: Financial Modeling Prep
BIOPHARMA CR PLC
No one on the platform currently holds BOPCF.
No tracked institution reports a position in BOPCF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-02 | $0.0175 | 2026-07-31 |
| 2026-05-01 | $0.0128 | 2026-05-29 |
| 2026-02-20 | $0.0107 | 2026-03-20 |
| 2026-02-20 | $0.0130 | 2026-03-20 |
| 2025-09-26 | $0.0150 | 2025-10-31 |
| 2025-09-26 | $0.0175 | 2025-10-31 |
| 2025-06-27 | $0.0127 | 2025-07-31 |
| 2025-04-04 | $0.0130 | 2025-05-07 |
| 2025-01-31 | $0.0090 | 2025-02-28 |
| 2025-01-31 | $0.0138 | 2025-02-28 |
No one on the platform has traded BOPCF yet.
| +0.00% |
| $909M |
| — |
| IOOFFInsignia Financial Ltd | $1.30 | +0.00% | $872M | — |
| LNTQFLeonteq AG | $49.48 | +0.00% | $889M | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2024-09-27 | $0.0154 | 2024-10-29 |
| 2024-09-27 | $0.0132 | 2024-10-29 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 4.5× earnings vs its 8.6× historical median P/E.
Fair value ≈ $1.85 · price $0.98 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.